Meeting
2019 ASCO Annual Meeting
Association of BRCA-mutant pancreatic cancer with high tumor mutational burden (TMB) and higher PD-L1 expression.
Authors
Andreas Seeber
Department of Internal Medicine V (Hematology and Oncology), Innsbruck, Austria
Andreas Seeber , Alberto Puccini , Joanne Xiu , Richard M. Goldberg , Axel Grothey , Anthony Frank Shields , Mohamed E. Salem , Francesca Battaglin , Wafik S. El-Deiry , Ryuma Tokunaga , Philip Agop Philip , John Marshall , Florian Kocher , Michael J. Hall , Wolfgang Michael Korn , Heinz-Josef Lenz , Gilbert Spizzo
Disclaimer
This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org
Poster Details
Session Type
Poster Session
Session Title
Gastrointestinal (Noncolorectal) Cancer
Track
Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary
Sub Track
Pancreatic Cancer
Citation
J Clin Oncol 37, 2019 (suppl; abstr 4133)
DOI
10.1200/JCO.2019.37.15_suppl.4133
Abstract #
4133
Poster Bd #
238
Abstract Disclosures
Similar Posters
Poster
2019 ASCO Annual Meeting
Frequency of BRCA mutation in biliary tract cancer and its correlation with tumor mutational burden (TMB) and microsatellite instability (MSI).
First Author: Gilbert Spizzo
Poster
2019 Gastrointestinal Cancers Symposium
Characteristics of colorectal cancer (CRC) patients with BRCA1 and BRCA2 mutations.
First Author: Madiha Naseem
Poster
2015 ASCO Annual Meeting
Multiplatform molecular profiling of pancreatic adenocarcinomas to identify BRCA1/2 mutations and PD-1/PD-L1 status with therapeutic implications.
First Author: Sherri Z. Millis
Poster
2024 ASCO Genitourinary Cancers Symposium
Malignant epithelioid angiomyolipoma (eAML)/PEComa of the kidney: A genomic landscape study.
First Author: Rebecca A Sager